Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
Titel:
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
Auteur:
Kudo, Masatoshi Finn, Richard S. Edeline, Julien Cattan, Stéphane Ogasawara, Sadahisa Palmer, Daniel H. Verslype, Chris Zagonel, Vittorina Fartoux, Laetitia Vogel, Arndt Sarker, Debashis Verset, Gontran Chan, Stephen L. Knox, Jennifer Daniele, Bruno Yau, Thomas Gurary, Ellen B. Siegel, Abby B. Wang, Anran Cheng, Ann-Lii Zhu, Andrew X.
Verschenen in:
European journal of cancer
Paginering:
Jaargang 167 () nr. C pagina's 1-12
Jaar:
2022
Inhoud:
Uitgever:
Masatoshi Kudo, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Laetitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer Knox, Bruno Daniele, Thomas Yau, Ellen B. Gurary, Abby B. Siegel, Anran Wang, Ann-Lii Cheng, Andrew X. Zhu, KEYNOTE-224 Investigators